Legacy Capital Group California, Inc. Catalent, Inc. Transaction History
Legacy Capital Group California, Inc.
- $301 Billion
- Q3 2024
A detailed history of Legacy Capital Group California, Inc. transactions in Catalent, Inc. stock. As of the latest transaction made, Legacy Capital Group California, Inc. holds 9,631 shares of CTLT stock, worth $568,421. This represents 0.19% of its overall portfolio holdings.
Number of Shares
9,631Holding current value
$568,421% of portfolio
0.19%Shares
1 transactions
Others Institutions Holding CTLT
# of Institutions
484Shares Held
160MCall Options Held
364KPut Options Held
837K-
Vanguard Group Inc Valley Forge, PA20.4MShares$1.2 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY15.4MShares$906 Million0.02% of portfolio
-
Nomura Holdings Inc Tokyo, M011MShares$649 Million1.22% of portfolio
-
State Street Corp Boston, MA7.34MShares$433 Million0.02% of portfolio
-
Barclays PLC London, X04.97MShares$293 Million0.09% of portfolio
About Catalent, Inc.
- Ticker CTLT
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 179,896,000
- Market Cap $10.6B
- Description
- Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...